Abstracts

HYDROGEN SULFIDE BLOCKS HIV REBOUND BY MAINTAINING CELLULAR REDOX HOMEOSTASIS

Understanding the mechanism of the establishment of HIV latency and its maintenance under antiretroviral treatment (ART) is of utmost importance. Previous studies suggest that the latent reservoir of HIV (monocytes and T cells) have elevated levels of redox buffers (e.g., glutathione [GSH] and thioredoxin [Trx]) and antioxidant enzymes (superoxide dismutase, catalase, peroxidase). Moreover, the role…

DEFECTIVE RNA-DIRECTED STRAND DISPLACEMENT DUE TO HIV-1 RIBONUCLEASE H INACTIVATION

In retroviruses, strand displacement DNA-dependent DNA synthesis catalyzed by the viral reverse transcriptase (RT) is required to obtain double-stranded proviral DNA. Strand displacement facilitates the elimination of uncleaved genomic RNA fragments during plus-strand DNA synthesis. In addition, strand displacement during RNA-dependent DNA synthesis is critical to generate high-quality cDNA for use in a variety of…

INTERACTOME OF HIV PROTEINS AND THEIR HOST RNA INTERACTION PARTNERS

The HIV genome encodes a limited set of proteins, depending heavily on the exploitation of host cell molecules to complete its viral life cycle. Recent findings show that HIV hijacks cellular (non-coding) RNA molecules to aid in these crucial viral replication processes. Therefore, this study aims to systematically determine this new layer of physical interactions…

VIRAL AND IMMUNE PREDICTORS OF TIME TO VIRAL REBOUND IN SHIV-INFECTED INFANT MACAQUES

Breastfeeding transmission remains a leading cause of pediatric HIV infections worldwide. Uncovering predictors of time to viral rebound (TTR) in a preclinical breastfeeding transmission model could identify clinical biomarkers to guide remission strategies and clinical trial design. At 4 wks of age, rhesus macaques (RMs) were orally infected with SHIV.C.CH505.375H.dCT and placed on daily ART…

DEVELOPMENT OF VIRAL BIOMARKERS IN SHIV INFECTED NONHUMAN PRIMATES

As HIV-1 infection has transformed from a fatal crisis into a chronic, life-long disease managed by anti-retroviral therapy (ART), attention has shifted towards curative therapies. A regimen which may allow for viral control off ART will likely require a combination of agents to address HIV reservoirs and induce immune control. These complex interactions are difficult…

ANTI-?4?7 ANTIBODY REDUCES INTESTINAL MYELOID CELL TURNOVER IN SIV-INFECTED MACAQUES

Despite advances in combination antiretroviral therapy (cART), HIV-infected individuals experience gastrointestinal symptoms and gut barrier dysfunction. Previous studies indicate anti-?4?7 integrin monoclonal antibodies (mAbs) reduce gut lymphoid aggregation in the gut and more recently, that they increased time to viral rebound when co-administered with broadly neutralizing Abs in SIV-infected macaques. However, the impact of anti-?4?7…

INNATE IMPAIRMENT DURING SIV INFECTION ALTERS ZIKV VIRAL PATHOGENESIS

Flaviviruses are in >100 countries across the globe and in areas with endemic HIV. Despite the occurrence of large flavivirus outbreaks and geographic overlap in countries with high HIV prevalence, there is insufficient research to determine the risks of flavivirus co-infection in people living with HIV and impact on co-morbidities. Here, in SIV-infected pigtail macaques,…